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Summary 
In  these  studies  we  have characterized  the  human  cells that  repopulate  severe combined 
immunodeficient (SCID) mice after injection of adult peripheral blood or cord blood (hu-PBD 
SCID mice). In all organs of the chimeras, and at any time point tested, single-positive (CD4 + 
or CD8 +) T  cells that expressed the or//3 T  cell receptor (TCR) prevailed. All T  cells were 
CD45RO * and the majority were also HLA-DR § . Thus,  the human T cells in the chimeras 
exhibited the phenotype of mature, memory cells that showed signs of recent activation.  Cell 
cycle studies revealed a mitotically active human T cell population in the murine host. However, 
when freshly isolated from the chimeras, the human T cells were refractory to stimulation by 
anti-CD3 antibody but proliferated in response to exogenous interleukin 2.  Chimera-derived 
human T  cell lines retained  this state of unresponsiveness to TCR-triggered proliferation  for 
4-6 wk in vitro.  Subsequently, the T  cell lines developed responses to anti-CD3 stimulation 
and 9 of 11 of the lines also proliferated in response to splenic stimulator cells of SCID mice. 
These data demonstrate that the human T cells are in a state of reversible anergy in the murine 
host and that xenoreactivity might play a critical role in hu-PBL-SCID mice. Mechanisms that 
may determine repopulation  of SCID mice with human peripheral blood mononuclear cells are 
discussed. 
T 
he CB.17 scid/scid  (SCID) mouse strain exhibits defec- 
tive recombination of antigen receptor genes (1) leading 
to an early arrest in T and B lymphocyte development and 
a resulting SCID. Therefore, SCID mice are unable to reject 
allogeneic  or ~enogeneic  transplants (2). This notion prompted 
the idea that SCID mice could be engrafted with human leu- 
kocytes and hematopoietic cells to constitute a chimera with 
a functional human immune system (3, 4). Such SCID mouse 
human chimeras would be of particular  interest for studies 
on human lymphocyte development  and functions in vivo 
in a readily accessible animal model. 
Construction of a functional human immune system in 
the SCID mouse has been pursued by introducing human 
lymphopoiesis into the mouse by grafting fetal human thymus, 
liver, and lymph nodes (4), or adult bone marrow (5); and 
transferring immunocompetent lymphocytes from peripheral 
blood into the mouse (hu-PBbSCID mice) (3). The first ap- 
proach resulted in long-term human lymphopoiesis  in the 
fetal human graft (6). Mature,  human T cells appeared in 
low numbers in the circulation  of the mice and proved to 
be phenotypically normal and functional when tested in vitro 
(7). However, it is unclear whether these T cells also could 
respond to antigen in the chimeras in the absence of human 
APC. Macrophages have not been detected in the chimeras 
(7) and B cells are poor APC for initiation ofT cell responses 
(8-10). Therefore, SCID mice transplanted with fetal human 
lymphopoietic organs might not provide experimental animals 
with a fully functional immune system. 
Theoretically, injection of SCID mice with human PBL 
transfers all the mature cell lineages required to constitute 
a functional immune system. High levels of human Ig were 
detected in such mice, indicating that mature human B lym- 
phocytes repopulated and functioned in the recipients (3, 11). 
However, the human B cells were present in the chimeras 
in low numbers and these B cells exhibited a rather limited 
clonal heterogeneity  (11). Furthermore, human T cells in hu- 
PBL-SCID mice had been detected infrequently and in low 
numbers and were, therefore, hard to analyze (12). With the 
human lymphocytes being at or beyond the detection limit, 
the nature of hu-PBL-SCID  chimerism  has  not yet been 
defined. 
Here we phenotypically and functionally characterize the 
human cells that populate  hu-PBL-SCID chimeras. We re- 
port that 1 to 2 mo after intraperitoneal  injection of SCID 
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become detectable by FACS  |  analysis and eventually consti- 
tute up to 50% of all mononuclear cells in the lungs, liver, 
and spleen of the recipient mice.  Except for low numbers 
of B cells, the human leukocytes consist of mature T  lym- 
phocytes which exhibit the phenotype of activated memory 
cells. The human lymphocytes proliferate in their secondary 
host. However, we find that the human T cells in the chimeras 
are refractory to stimulation through the TCR but proliferate 
in response to IL-2. Human T  cell lines established from hu- 
PBL-SCID mice retain this state of unresponsiveness during 
the first weeks of culture; subsequently, the lines become func- 
tional  and  proliferate to SCID-splenic  stimulator  cells. 
Materials and Methods 
Subjects.  PBMC donors were 11 healthy subjects  (eight men 
and three women) between the ages of 22 and 45 yr. Three of these 
donors had not been infected with EBV as judged by a lack of serum 
antibodies for EBV and by gene amplification to EBV genome (13, 
14) using their PBMC DNA (see below). Cord blood from six 
newborns was kindly provided by Y. J. Bryson, UCLA School of 
Medicine.  Four normal subjects  provided bone marrow (one was 
EBV seronegative and genome negative). Thymus specimens were 
obtained in the course of cardiac surgery from two children under 
5 yr of age. The thymus cell suspension  was kindly provided by 
C. H. Uittenbogaart, UCLA School of Medicine. A human, im- 
mature T leukemia cell line, CCRF-CEM (CEM), grown continu- 
ously in serum-free medium, was provided by C. H. Uittenbogaart. 
Mice and Cell Transfer.  CB.17 SCID mice were bred at UCLA 
under sterile conditions and maintained in a pathogen-free envi- 
ronment without prophylactic antibiotic treatment. This colony, 
begun from founders delivered by cesarian section, has been screened 
for the presence  of mouse pathogens. SCID mice were between 
6 and 12 wk old at the time of cell transfer. PBMC and cord blood 
cells were isolated from blood by density gradient centrifugation 
(Lymphoprep; Nycomed Pharma AS, Oslo, Norway). Bone marrow 
was used either unmanipulated or as mononuclear cell suspension 
after Lymphoprep separation. The human cells were injected in- 
traperitoneally in 1 ml of PBS into SCID mice via a 23-gauge needle. 
The number of cells injected in each experiment is indicated in 
the results. No mice developed frank human lymphoid tumors when 
observed up to 200 d after human cell transfer. 
Human lg Measurements.  After transplantation with human cells, 
mice were bled every 2 wk from the tail vein and human serum 
Ig levels were measured by isotype-specific ELISAs as described in 
detail elsewhere (15). The detection limit of the assay for human 
IgG was 2.5 ng/ml. Hu-PBL-SCID mice sera were usually diluted 
between 1:25,000 and 1:250,000.  Sera from naive SCID mice and 
BALB/c mice gave no measurable human Ig signal in the ELISAs, 
even at a dilution of 1:20. 
Recovery of Human Cells  from Grafted SCID Mice.  Heparinized 
blood was collected from the tail vein of mice. Subsequently, the 
mice were killed by cervical dislocation and the spleen, liver, thymus, 
lymph nodes, and lungs were collected.  Single cell suspensions  of 
these organs were obtained by gently teasing the tissue with the 
back of a syringe in sterile medium and passing the resulting mix- 
ture through a sterile wire mesh. Bone marrow cells were flushed 
out of the femoral cavity with PBS. Peritoneal cells were obtained 
by lavage with 2-4 ml PBS. 
Flow Cytometric Analysis and Antibodies Used  for Staining.  Two- 
and three-color flow cytometric analyses were performed as previ- 
ously described (16). Briefly, 0.3-1.0  x  106 cells were stained with 
optimal concentration of antibody for 45 min at 4~  and then 
washed three times. For indirect staining, second antibodies or strep- 
tavidin conjugates were incubated for 45 min at 4~  After washing, 
cells were lysed with Coulter Lyse and fixed with Coulter Fix 
(Coulter Corporation, Hialeah, FL) before washing three times. 
All steps were performed in Coulter PBS (Coulter Corporation). 
Analysis  of fixed cells was performed over the next 2 d using a 
FACScan  |  (Becton Dickinson Immunocytometry Systems, Moun- 
tain  View,  CA).  We  purchased  from  Becton  Dickinson  Im- 
munocytometry Systems the following antibodies which are specific 
for human cell surface markers:  CD3 (FITC and PE), CD4 (FITC 
and PE), CD5 (FITC), CD8 (PE), CD19 (PE), CD20 (PE), CD25 
(PE), CD45 (FITC), CD45RA (FITC), anti-Transferrin Receptor 
(FITC),  HLA-DR  (FITC,  PE),  TCR ct//~ (FITC),  TCR y/t~ 
(FITC), Leu8 (FITC), and CDla-purified antibody. All mouse iso- 
type controls  were also  obtained  from Becton Dickinson  Im- 
munocytometry Systems. The monoclonal specific for CD45RO 
(FITC) was purchased from Dako Corporation (Santa Barbara, CA). 
Biotinylated anti-H-2K  d was  purchased from Pharmingen  (San 
Diego, CA). PE-conjugated streptavidin came from Caltag Labora- 
tories (South San Francisco,  CA). All these antibodies exhibited 
species specificity when tested on mouse and human cells. To ex- 
clude the possibility of murine cells staining nonspecifically  for 
human markers (12), we used two-color FACS  |  analysis. Human 
cells were stained  for the leukocyte common antigen CD45 and 
murine cells were stained for the murine MHC class I molecule 
H-2K  a.  The antibodies did not cross-react  between cells of the 
two species (Fig. 3 A), and we could clearly distinguish cells of 
human (CD45 +, H-2Kd-), and routine (CD45-, H-2K  d§  origin 
in engrafted mice. Cell mixing experiments revealed the detection 
limit of 1 human cell in 1,000  murine cells (data  not shown). 
Cell Cycle Analysis.  Cell cycle analysis was performed as de- 
scribed (16, 17). Cells were first stained with FITC-labe|ed anti-CD3 
or anti-CD45 antibodies (see above), fixed in 2% paraformalde- 
hyde solution, and the membranes were permeabilized with 0.2% 
Tween 20 (Sigma  Chemical Co., St. Louis,  MO) in PBS. DNA 
was  stained  by incubating  106 cells in  1 ml of PBS containing 
10 #g/ml of propidium iodide (Calbiochem Corp., La Jolla, CA) 
and 11.25 Kunitz Units of RNase (Sigma Chemical Co.) for 30 
rain. The samples were analyzed on a FACScan  |  flow cytometer 
(see above). 
T Cell Proliferation Assay with Cells Freshly Prepared  from Chimera 
Organs.  Single-cell suspensions were prepared from the lungs, liver, 
and spleen of individual mice as described above. Cells were pooled 
and the relative number of human (CD45 +) vs. murine (H-2K  d) 
cells was determined by FACS  |  analysis. The cell suspension  was 
plated into 96-well  flat-bottomed plates  (Coming Glass Works, 
Coming, NY) titrating from l& to 104 cells per well. The number 
of human cells per well was calculated by subjecting the cell sus- 
pension to FACS  |  analysis and determining the routine/human cell 
ratio (usually 20-50%). Human APC were added. The APCs were 
derived from the same human donor with whose cells the hu-PBb 
SCID mouse had been reconstituted. The APC comprised PBMC 
that had been depleted of T cells by rosetting with sheep erythro- 
cytes (18) and then irradiated (3,000 rad). Anti-CD3 antibody (Or- 
thoclone OKT3; Ortho Pharmaceutical Corp., Raritan, NJ) was 
used at 1/~g/ml final concentration, which has been established 
as maximally stimulatory for human PBMC and T cell lines, rlL-2 
(a gift of Sandoz Ltd., Basel, Switzerland) was used at 10 ng/ml 
final concentration. The culture medium consisted of DMEM sup- 
plemented with 10% FCS, 1% glutamine, 1% nonessential amino 
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[3H]thymidine was added to each well. 18 h later, the plates were 
harvested and 3H incorporation was counted by liquid scintillation. 
The results are expressed as incorporation of radiolabel  by the cells 
(arithmetic mean  _+  SD). 
Generation of  Human T Cell Lines  from hu-PBI_,SCID  Mice.  Pri- 
mary cultures from hu-PBL-SCID  mice contained (a) a single cell 
suspension from  the  organs of the chimeras at 4  ￿  106  total 
cells/ml,  (b)  irradiated, syngeneic, human PBMC  at  2  x  106 
cells/ml; (c) anti-CD3 mAb at 1 #g/ml; and (d) rIL-2 at 10 ng/ml 
final concentration. The culture was performed in 24-well plates 
(Coming Glass Works) in 2 ml of  DMEM-FCS medium (see above). 
7 d later, viable cells were readjusted to 3  x  10  s cells/ml and cul- 
tured in 24-weU plates in DMEM-FCS medium containing rib2 
(10 ng/ml). At this point no feeder  cells or CD3 mAb were added. 
On day 15 the lines were readjusted to 2  x  10  s ceUs/ml and were 
restimulated with irradiated, syngeneic, human APC (PBMC, 2 
x  106/ml), CD3 mAb (1/zg/ml), and rlL-2 (10 ng/ml) in 24-well 
plates in 2 ml DMEM-FCS medium per well. Thereafter, the cells 
were fed weekly with fresh DMEM-FCS medium containing rib2 
(10 ng/ml) and restimulated with syngeneic, human APC and Ag 
(CD3 mAb) once a month according to the protocol previously 
described (19). 
T  Cell Proliferation Assay with Chimera-derived Human T  Cell 
Lines.  T cells lines were not tested within 2 wk of restimulation 
with CD3 antibody and APC. Thereafter, the assays, were per- 
formed with 3  x  104 cells of the chimera-derived  cell line (<97% 
CD45 ~,  CD3 +  by  day  15)  and  10  s  human,  autologous,  T 
cell-depleted (E-rosetting), irradiated (3,000 tad) PBMC as APC. 
The proliferative potential of the line was assayed  by polyclonal 
stimulation with CD3 mAb (1 ~g/ml) or PHA (Sigma Chemical 
Co.) at 3/zg/ml which formally has been established as the op- 
timal concentration for induction ofblastogenesis. The antisecon- 
dary host response was tested  by adding irradiated  (3,000 tad), SCID- 
splenic stimulator cells at 2  x  105 cells/well. The cells were cul- 
tured in 200 ml complete DMEM in 96-well flat-bottomed plates 
(Coming Glass Works). After 3 d of culture, 1/zCi [3H]thymi- 
dine was added to each well. The plates were harvested 18 h later, 
and [3H]thymidine incorporation was assayed by liquid scintilla- 
tion counting as described above. 
Gene Amplification (PCR) for EBV Genome.  DNA was prepared 
for PCR. according to Higuchi (14). Cells were washed twice with 
PBS and resuspended at 6  x  106 ceUs/ml in PCR buffer (50 mM 
KC1, 10  mM Tris-HC1, pH  8.3, 2.5  mM MgClz 0.1  mg/ml 
gelatin, 0.45% NP-40, 0.45% Tween 20). This mixture was in- 
cubated with 10 #g/ml of proteinase K for 1 h at 60~  and then 
at 95~  for I0 min. The samples were then frozen at - 70~  until 
used. Nucleotides 1396-1520 of the EBV BamW region were 
amplified with primers TC-60: 5'dCCAGAGGTAAGTGGACTT 
and TC-61: 5'dGACCGGTGCCTTCTTAGG developed  by Fox et 
al. (13) and synthesized by Genosys, Inc. (Houston,  TX).  Each 
PCR reaction mixture contained 1/zg PCR-prepared DNA, 300 
pM TC-60 and TC-61 primers, 100 pM dNTP pools and PCR reac- 
tion buffer (10 mM Tris-HC1 at pH 8.3, 50 mM KC1, 1.5 mM 
MgClz, 0.001% gelatin (No. G2500; Sigma Chemical Co.). Each 
sample was capped with 50/zl of light mineral oil, then denatured 
(94~  10 rain) and cooled (55~  30 rain). 2.5 U  of Thermus 
aquaticus (Taq) DNA polymerase (Perkin-Elmer/Cetus, Norwalk, 
CT) was added to each sample bringing the final reaction volume 
to 100 #1. The samples were subjected to 40 successive cycles of 
denaturation (91~  1 min), primer annealing (72~  1 min) and 
primer extension (65~  2 min). All reactions were performed in 
a DNA Thermal Cycler (Perkin-Elmer/Cetus). For Southern blot 
analysis of the PCR products, 10 #I of  each amplified  DNA sample 
was run on a 1.6% agarose  gel and transferred  to a Zeta-Probe  blot- 
ting membrane (Bio-Rad Laboratories, Richmond, CA). This was 
then hybridized with 20 pg of an 32p end-labeled oligonucleotide 
sequence (TC62 =  dTTCTGCTAAGCCAACC [131) internal to 
the primers; then rinsed twice in 2  x  SSPE (1  x  SSPE: 0.18 M 
NaC1, 10 mM NaH2PO4, 1 mM EDTA, pH 7.4) and 0.05% SDS 
for 15 rain at room temperature. 
Results 
The persistence of mature human leukocytes in SCID mice, 
as well as the establishment of human hematopoiesis in the 
mice after transfer of human lymphoid cells, depend on poorly 
understood cooperative effects between the different cell types 
of the graft as well as host factors.  Initially, we tested cells 
from various human lymphoid organs to determine which 
cells would provide the most favorable reconstitution of a 
human immune system in the xenogeneic recipient. We in- 
jected unmanipulated SCID mice intraperitoneally with single 
cell  suspensions  from PBL, cord blood, bone marrow,  or 
thymus. The success of engraftment was monitored by FACS  | 
analysis of the organs of grafted mice for the presence of var- 
ious human leukocyte populations, and measuring human 
Ig in the serum of the recipient mice. 
Human Leukocytes Can Be Readily Detected in SCID Mice 
Injected with PBMC and Cord Blood, but Not in Mice Injected 
with Bone Marrow or Thymocytes.  The organs of grafted SCID 
mice were analyzed for human leukocytes at different times 
after transplantation. Representative data selected  from 59 
mice tested individually are shown in Table  1.  In the first 
20 d after intraperitoneal inoculation of PBL, human leuko- 
cytes could be detected at the site of injection, in the perito- 
neal cavity,  but not in other organs of the mice. Initially, 
the number of human cells dropped dramatically: from 10.0 
x  106 injected PBL •  0.01  x  10  ~ cells (1:1,000) were re- 
covered  from the peritoneal cavity 7 d later.  At about day 
30 after reconstitution with PBL or cord blood, human leu- 
kocytes became detectable in various organs of the mice (Table 
1). The number of human cells increased steadily within the 
first 3 mo after injection to eventually constitute up to 50% 
of all mononuclear cells recovered from the organs of  chimeras. 
Subsequently, the number of human cells declined so that 
by day 200, generally no human cells could be detected. The 
disappearance of the human cells was associated with the de- 
cline of human serum Ig levels in the mouse (see below). 
We could not detect human leukocytes in the mice injected 
with bone marrow and thymocytes early or late after grafting 
(Table 1). 
Human Ig's Can Be Detected in Sera of SCID Mice Injected 
with  PBMC,  Cord Blood and,  to  a  Lesser Extent,  Bone 
Marrow.  When  10-15  million PBMC from five different 
donors were injected, 15 of 34 mice (44%) developed human 
serum Ig levels >700/ag/ml, which was indicative of the pres- 
ence of human cells (see below). After injection of 20 mil- 
lion PBMC from six different donors, 22 of 40 mice (55%) 
became positive for human Ig's. Representative data from these 
experiments are shown in Fig. 1 A. Since injection of higher 
numbers of PBMC did not yield better results but led to in- 
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20 million PBMC for reconstitution in subsequent  experi- 
ments. We did not observe an influence of the donor's EBV 
status  on  the  reconstitution.  We  injected  57  mice  with 
EBV + PBL and only two (3.5%)  developed a B  cell lym- 
phoma as  detected  by PCR. 
After injection of 20 million cord blood mononuclear cells 
from five different donors, 5 of 26 mice (19%) exhibited human 
Ig's >700 #g/ml in their serum over an observation period 
of 100 d. Five of five mice injected with 35 million cord blood 
cells were found to be reconstituted by this criterion  (Fig. 
1, B). The time course, as well as the peak Ig concentration, 
was comparable in cord blood- and PBMC-reconstituted mice. 
IgG was the predominant human Ig class in the chimeras. 
Essentially identical results were obtained for IgM (data not 
shown). 
We inoculated bone marrow cells from four different donors 
at  10-30 million mononuclear cells per recipient  mouse.  4 
of 11 injected animals developed detectable human Ig's, but 
the serum concentration was rather low (Fig.  1,  C).  After 
injection of human thymocytes, which contain up to 3% B 
cells  (21),  no human Ig was detected  (Fig.  1 D). 
Correlation Between Human Leukocytes and Human Ig Levels 
in the Chimeras.  As stated before, PBL of some human donors 
consistently failed to induce production of human Ig in SCID 
mice. Even "good" donors gave rise to high level Ig produc- 
Table  1.  Detection  of human CD45  § leukocytes in SCID mice 
Human cells injected 
Percent  CD45 § leukocytes detected in organs of chimeras 
Tested  Intraperitoneal  Bone 
Type  Donor  No.  on day  Human Ig*  fluid  Lung  Liver  Spleen  Thymus  marrow  Blood 
x 106  ~g/ml 
PBMC  A  10  7  0  10  <1  <1  0  0  0  0 
F  20  30  35  <1  0  0  0  0  0  0 
A  20  34  3,275  67  24  23  42  10  <1  7 
A  10  35  2,848  ND  22  20  32  ND  1  4 
D  20  35  1,413  49  21  18  48  62  1  2 
F  20  63  14,825  26  38  21  57  19  9  ND 
B  10  74  790  ND  54  35  12  22  1  3 
A  20  97  1,408  7  9  10  34  0  2  0 
F  20  115  3,868  24  18  7  3  9  1  14 
A  10  164  254  0  3  2  3  <1  <1  0 
Cord blood  N  35  33  1,700  36  4  1  <1  <1  0  <1 
L  20  45  1,938  22  2  0  0  48  0  0 
N  35  54  3,000  64  23  11  43  10  1  2 
L  20  121  8,108  <1  6  6  8  17  2  2 
L  20  132  236  2  0  0  0  0  0  0 
Thymocytes  T  100  53  0  0  0  0  0  0  0  0 
S  20  70  0  0  0  0  0  0  0  0 
S  20  70  0  0  0  0  0  0  0  0 
T  100  122  0  0  0  0  0  0  0  0 
Bone marrow  J  30  55  0  0  0  0  0  0  0  0 
K  10  81  0  0  0  0  0  0  0  0 
J  30  153  258  0  0  0  0  0  0  0 
J  30  153  163  0  0  0  0  0  0  0 
Mice were injected intraperitoneally with human PBMC, cord blood mononuclear cells, thymocytes or bone marrow cells. Donors are ide ,tiffed 
by capital letters and the number of cells grafted is shown. On the days indicated, recipient mice were killed, and single cell suspensions  ,f the 
organs were studied by two-color FACS  |  analysis. Human leukocytes were stained with anti-CD45-FITC and murine cells were identified by anti- 
H-2Kd-pE. The  frequency of human leukocytes within  an  organ is expressed as percent CD45*  cells [%CD45  =  100 x  (CD45 +  ,  H-2K  d- 
cells/CD45-, H-2K  d*, ungated)]. 
" Human serum Ig levels in the mice on the day of FACS  |  analysis. 
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Figure  1.  Detection of human 
Ig's in sera of SCID mice trans- 
planted  with  human  lymphoid 
tissues. Human cells were injected 
in  single cell suspension intra- 
peritoneally. Recipient mice were 
bled biweekly.  The concentration  of 
human antibodies  in the serum was 
tested  by  ELISA. (.4) PBMC- 
injected mice after inoculation of 2 
x  107 cells. Individual mice, each 
grafted with  cells of a different 
donor are shown. The data are rep- 
resentative  for a total of 30 mice in- 
jected with PBMC of six donors. 
Antibody production  was donor de- 
pendent. PBL of some donors con- 
sistently failed to  repopulate the 
mice in repeated experiments. (B) 
Cord blood-injected mice, after in- 
oculation of 2-3.5  x  107 cells. In- 
dividual mice are shown. Symbols 
denote different  donors. The data are 
representative of 26 mice injected 
with five donors. ((2) Bone mar- 
row-injected  mice. 1-2  x  107 
(closed  symbols) and 3  x  10  7 (open 
symbols) from four donors (m, A, 
0, A) were injected. None out of 
11 injected mice developed  human 
IgG >700 ~g/ml in their serum. 
(D) Thymocyte-injected mice. In 
two experiments, 2  x  107 cells of 
one donor (closed symbols, eight 
mice) and  10  x  107 of another 
donor (open symbols, three mice) 
were injected. 
tion in only 75% of the injected mice. In mice that did not 
develop human Ig levels >700 #g/ml, no human cells could 
be detected by FACS  |  analysis,  irrespective of whether the 
mice were tested early or late after transplantation (13 of 13 
mice tested). Conversely, animals with human Ig >700 #g/ml 
had detectable numbers of human leukocytes (36 of 39 mice) 
as well. Furthermore, the decline of human Ig in reconstituted 
mice was associated with human cells dropping beyond the 
detection limit in chimeras (seven of seven mice). These data 
are summarized  in Fig.  2 A.  Regression  analysis for PBL- 
injected mice (see Fig. 2 A legend) revealed a highly significant 
correlation between human IgG levels and the detectability 
of human leukocytes in the lungs. Virtually identical correla- 
tion was found for the liver. The analysis indicates  that  to 
achieve a 95% probability of finding a non-zero number of 
CD45 + cells in these organs, animals with human IgG levels 
>700/xg/ml have to be selected. The correlation was weaker 
in the spleen and, due to fewer data points, in human cord 
blood injected mice. Occasionally, the human cells were abun- 
dant in one of the chimera's organs (lung, liver, or spleen), 
but  low in number  in  the other organs  (Fig.  2  B). 
Human Leukocytes Preferentially Reside in the Lungs, Liver, 
and Spleen of  the Chimeras. Few Human Cells Repopulate  Mouse 
Thymus, Bone Marrow, and Lymph Nodes.  After injection of 
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PBL or cord blood cells, human leukocytes were detected in 
all organs of the chimeras that were accessible to FACS  |  anal- 
ysis (Table 1). However, the human cells were preferentially 
found in the lungs,  liver,  and  spleen (Fig.  2 B).  Less than 
4%  of the cells in  the bone marrow  were CD45 +.  Occa- 
sionally, a mouse thymus contained up to 60% human cells, 
but this is deceptive as the thymus of the chimeras, like the 
thymus of SCID mice, is rudimentary and consists of <3  x 
106 cells (normal, age-matched murine thymuses have 100- 
300  x  106 cells).  Also,  the lymph  nodes of the chimeras 
were hypoplastic, typically being too small to detect visually. 
Thus, based on absolute numbers, >96% of the human leu- 
kocytes recovered from the chimeras were found in the lungs, 
liver,  and  spleen. 
The Predominant  Human Cell Type in the Chimeras Are Ma- 
ture T  Lymphocytes that Express Activation Markers.  In  all 
organs of the chimeras,  human T  cells prevailed (Table 2). 
This dominance of T cells was seen in all chimeras (30 mice), 
irrespective of whether PBL or cord blood cells were used 
for reconstitution, and irrespective of the time point at which 
the mice were analyzed after transplantation. Human B cells 
(CD19 §  and/or  CD20 §  were  detected  in  7  of 23  PBL- 
reconstituted and five of seven cord blood-injected mice. The 
number and tissue distribution of B cells showed a high de- 80" 
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Figure 2.  Detection of human leukocytes in hu-PBL-SCID mice. In all 
panels filled symbols represent PBbinjected mice, open symbols represent 
cord blood-injected mice.  Symbols used for organs of the chimeras are 
lungs (squares), livers (triangles), and spleens (circles). (.4) Corrdation be- 
tween human serum Ig levels and the detectability of human leukocytes. 
The  percentage  of  CD45 §  H-2K  d-  cells  in  lungs  of PBb  or  cord 
blood-injected chimeras was defined by FACS  |  analysis (see Table 1, legend) 
and plotted against the concentration of human lgG in the serum for in- 
dividual mice (measured by ELISA). All mice tested during our study are 
included, irrespective of the donor or time point after grafting (7-164 d 
after injection, n  =  50). Statistical analysis of the correhtion between human 
IgG levels and human leukocytes in the lungs of PBbinjected mice:  r 2 
=  0.363,  t  =  4.45, p  <  0.001,  F  =  19.8.  Similar correlation was seen 
for the liver and spleen of PBL-injected mice:  r  2  =  0.363,  t  =  4.45, p 
< 0.001, F  =  19.8 and r  2 =  0.170, t  =  2.8, p < 0.009, F  =  7.76, respec- 
tively (not plotted)￿9 The correlation for lungs of cord blood-grafted mice 
(n  =  8): r2  =  0.397, t  =  4.45, p <  0.056, F  =  5.62.  The data for liver 
and spleen of cord blood-injected mice: r z  =  0.123,  t  =  1.5, p  <  0.18, 
F  =  2.24 and r  2 =  0.123, t  =  1.0, p <  0.35, F  =  0.98.  Note that when 
few human leukocytes were present in the lungs of Ig + mice, CD45 + 
cells frequently were abundant in the liver or spleen (B).  (B) Absolute 
numbers of CD45 + cells recovered from lungs, livers, and spleens of in- 
dividualchimeras. Representative data are shown for chimeras (human IgG 
>  700 gg/ml) that had been tested 35-80 d after transplantation. For cal- 
culation of absolute numbers, the percentage of CD45 +,  H-2K d-  cells 
within the ungated single-cell suspension of an organ was determined by 
two-color FACS  "~ analysis.  With human cell counts <<1 million per organ 
of chimeras, data for thymus, bone marrow, blood and intraperitoneal fluid 
gree of inter-individual variation. In some chimeras, particu- 
larly in cord blood-injected mice, the thymus and the spleen 
contained up to 77.7% B lymphocytes (Table 2). We tested 
whether the occasional occurrence of a high percentage of 
B cells in the chimeras was related to EBV tumors: PCR could 
not detect the EBV genome in the cells in question. The pres- 
ence of human B cells in the thymus of the chimeras might 
reflect a physiologic outcome of the transplantation since ma- 
ture B cells constitute 3% of the thymocytes in adult, healthy 
mice (20),  as well as in humans  (21). 
Fig. 3 shows results of FACS  |  analysis obtained with the 
thymus of an individual PBbreconstituted mouse. The data 
are representative  of all  organs  (spleen,  lungs,  liver,  bone 
marrow, and lymph nodes) of 36 chimeras  tested individu- 
ally, between days 35 and  164 after grafting.  As shown in 
Fig. 3 A, we could clearly distinguish between cells of mu- 
fine  (H-2K  d+,  CD45-)  and  cells  of  human  (H-2K  d-, 
CD45 +) origin.  Human cells  constituted 20%  of all cells 
in the thymus of this mouse.  Furthermore,  it is clear that 
all human cells in the chimera were leukocytes, since we did 
not  detect  an  H-2K  a-,  CD45-  cell  population.  In  this 
mouse,  basically all  CD45 + cells  represented  T  cells  that 
stained with CD3 (Fig. 3 B) and with CD2 (data not shown). 
Less  than  1%  B  cells  were detected  (Fig.  3  C).  In  other 
chimeras in which B cells are present (Table 2), B and T cells 
accounted for >99%  of the CD45 §  cells.  Thus,  T  and B 
cells  were  the  only human  leukocytes we detected in  the 
chimeras.  The CD3 + T  cells expressed CD4 or CD8 in a 
mutually exclusive manner (Fig. 3, D-F). In general, the ratio 
of CD4 +  to  CD8 +  cells  showed  a  high  degree  of inter- 
individual variability in hu-PBLSCID mice with dominance 
of either cell type (Fig. 2 C; the normal range for CD4/CD8 
ratio  in  adult  PBL is 0.93-4.5).  Double-positive (CD4 § , 
CD8 +) T cells were occasionally seen in low numbers (<4% 
of CD45 +  cells)  in  various  organs  of the  chimeras.  The 
double positive cells also expressed the marker CD45RO (Fig. 
3./). 
All T  cells in the chimera expressed the c~/B TCR and 
no 3,/t3 cells were detected (Fig.  3,  G  and H).  All T  cells 
were positive for CD45RO, the low molecular weight iso- 
form of CD45,  and were negative for CD45RA (Fig.  3, I 
and J). Also, most T  cells were HLA-DR § (Fig. 3 K), and 
did not express the homing receptor Leu8 (Fig.  3 L). Essen- 
tially identical results were obtained after staining organs of 
cord blood-reconstituted SCID mice (Fig. 4): T cells prevailed 
that had the phenotype of mature (CD4* or CD8 +), mem- 
ory-type (CD45KO +,  CD45RA-),  and recently activated 
(HLA-DR +,  Leu-8-)  T  lymphocytes. 
are not represented. (C) CD4/CD8 ratio in the chimeras. Mice that have 
been tested 30-70 d after injection of PBL or cord blood are shown. The 
percentage  of CD45 +,  CD4 +,  and  CD45 +,  CD8 +  cells  within  the 
CD45 + population was determined by two-color FACS  |  analysis and the 
CD4/CD8  quotient  was  calculated.  The ratio was  comparable  within 
different organs of individual mice,  showed donor dependence and did 
not appear to change with  time (not shown). 
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Relative percent  CD45 § cells 
PBMC-reconstituted  mice  Cord blood-reconstituted mice 
T  B  T  B 
SCID organ  (CD3 ~  )  (CD19 +  ,CD20 §  )  (CD3 *)  (CD19 §  ,CD20 § 
Blood  >99  x  0.0  <0.0  x  0.0  >99  x  0.0  <0.0  _+  0.0 
Bone marrow  >99  +_  0.0  <0.0  +_  0.0  >99  _+ 0.0  <0.0  _+ 0.0 
Thymus  97.1  _+  9.5  2.9  x  9.5  82.3  _+  28.6  17.6  +  28.6* 
Peritoneal fluid  97.7  _+  5.6  2.2  _+  5.6  99.3  +_  0.9  0.6  _+  0.9 
Spleen  98.7  +_  4.7  1.2  _+ 4.7  88.1  +_  22.5  11.8  +_  22.5 
Liver  99.2  _+  1.9  0.7  +  1.9  97.4  _+  3.9  2.5  _+  4.0 
Lungs  99.6  _+  0.8  0.4  _+  0.8  89.1  _+  14.8  10.8  _+  14.8 
Data obtained from analysis of 23 PBMC- and seven cord blood-grafted SCID mice are summarized. Mice were killed between days 30 and 160 
after grafting, and the indicated organs were studied by two-color FACS  |  analysis. The antibody combination CD45-FITC and CD19/CD20-PE 
was used to detected B cells. T cells were stained with CD45-FITC and CD3-PE (original data are plotted in Figs. 3 and 4). The high standard 
deviations are due to the occasional occurrence  of B cells in high numbers, i.e., in the thymus of cord blood-injected mice. 
*77.7%, 2.3%, 43.1%, 0%, 0%, 0%, 0% were B cells. 
Human  T  Ceils Proliferate in the Chimeras.  Proliferation 
of human T cells in the mice was suggested by the fact that 
the number of T  cells recovered increased with time (Table 
1).  To define the mitotic activity of the human T  cells in 
vivo in the chimeras, we analyzed cells freshly isolated from 
the chimeras. Propidium iodide was used to stain DNA, while 
cells were labeled with the anti-CD3 antibody. This allowed 
us to determine the DNA content of the human T  cells by 
two-color FACS  |  analysis.  As shown in Fig. 5 A,  18% of 
the CD3 § cells in a chimera were in the process of DNA 
replication  (stages  S,  G2,  and  M  of the  cell cycle). This 
represents a rather rapid mitotic activity since the continu- 
ously growing human immature T leukemia cell line CEM 
exhibits 44% of its cells in the process of DNA replication 
when tested under the same conditions (Fig. 5 C). As a nega- 
tive control, we used otherwise untreated, freshly isolated 
human PBL that showed no evidence of DNA replication 
(Fig.  5 B). 
Human T Cells in the Chimera Are in a State of Anergy from 
which They Recover after Long-Term Culture In Vitro Displaying 
Xenoreactivity.  We next tested whether the human T  cells 
in the chimeras were functional. Cells were isolated from the 
chimeras' organs and tested in vitro for proliferation to stim- 
ulation via the TCR. The T  cells did not respond to trig- 
gering with the anti-CD3 antibody in the presence (or ab- 
sence) of syngeneic human APC (T cell-depleted, irradiated 
PBL) (Table 3). We also did not detect I1.-2 in the superna- 
tant after stimulation. The complete lack of a proliferative 
or I1:2 response was also seen after stimulation with the T 
cell mitogen PHA (data not shown). However, the freshly 
isolated human T  cells from the chimeras did proliferate in 
the presence of exogenous II:2 (Table 3). 
We established 11 long-term, human T cell lines from hu- 
PB1:SCID by culturing freshly isolated cells with anti-CD3 
and I1:2 in the presence of syngeneic, human feeder cells (see 
Materials and Methods). This protocol was chosen to assure 
polyclonal expansion of the chimera-derived human T cells. 
As determined by FACS  |  analysis, by day 15 of the culture, 
the cell lines consisted <97%  of human T  cells  (data not 
shown). At this time, all the T cell lines were still refractory 
to stimulation by the CD3 antibody (Table 3). When seven 
lines were tested on day 40, three lines responded with prolifer- 
ation to CD3 stimulation while four lines were still unrespon- 
sive. After 2 mo of culture, all cell lines displayed prolifera- 
tive responses  to  CD3  (Table  3)  and  this  functional state 
remained stable over the next 6 mo. 
After the human T cell lines established from the chimeras 
had become responsive to stimulation via CD3,  we tested 
whether these lines  exhibited xenoreactivity to murine an- 
tigens. The T  cells were cultured with SCID spleen stimu- 
lator cells in the presence of human APC (T cell-depleted, 
syngeneic,  irradiated  PBMC).  As  shown  in  Table  3,  the 
majority ofT cell lines proliferated specifically to SCID stimu- 
lator cells (9 of 11 lines tested in total). No proliferation was 
elicited by C57.BL/6 splenic stimulator cells (data not shown). 
The xenoreactivity of the T  cell lines  was maintained over 
the entire period of subsequent culture (180 d) in which the 
lines were expanded polyclonally  by anti-CD3 and II.-2 stim- 
ulation. The xenoresponse was dependent on the presence 
of syngeneic human APC (data not shown). The two lines 
that  did not  proliferate to  SCID  stimulator  cells  consist- 
ed  predominantly of CD8 +  lymphocytes (92  and  97%), 
whereas  in  the  responding  lines  CD4 +  cells  dominated 
(>60%). 
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Figure  3.  Phenotypic character- 
ization of human leukocytes in hu- 
PBL-SCID mice. Two-color FACS  | 
analysis of the thymus of a chimera 
50 d after  grafting with 20  x  106 
PBMC.  In all diagrams,  the anti- 
bodies  for  fluorescence  I  (x-axis) 
were  FITC-labeled  and  the  anti- 
bodies for fluorescence 2 (y =  axis) 
were  PE  labeled.  Identical  results 
were obtained by analyzing the liver, 
spleen,  and lungs of the same chi- 
mera (not  shown). 
Discussion 
Establishment of a human immune system after  transfer 
of human lymphoid cells into SCID mice may be achieved 
in four different ways:  I.  Human stem cells may home to 
murine primary lymphoid tissues (bone marrow and thymus) 
or to tissues that can support hematopoiesis (liver and spleen) 
where they give rise to human lymphoid lineages. Resulting 
mature lymphocytes may repopulate the secondary lymphoid 
tissues to eventually form a functional immune system.  II. 
Mature human lymphocytes may persist in the mouse (22). 
In this case the life span and function of individual human 
leukocyte lineages after transplantation will define the human 
immune system in the chimera.  For example,  it is conceiv- 
able that certain long-lived lymphocytes  (22) persist in the 
secondary host while short-lived lymphocytes (23) would die 
offrather rapidly. III. It is possible that mechanisms that regu- 
late leukocyte homeostasis drive the repopulation of the mice 
(24, 25). In this case, certain self-replenishing leukocyte lineages 
(26),  which have the capacity to proliferate in the absence 
of antigenic stimulation, may repopulate the mice.  IV. It is 
possible that the human cells do react  to murine antigens 
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Figure  4.  Phenotypic characteriza- 
tion of the human leukocytes in cord 
blood-reconstituted SCID mice. Two- 
color FACS  |  analysis with the thymus, 
liver, and lungs of a chimera 54 d after 
grafting. Antibodies for fluorescence 1 
(x-axis) were FITC, and antibodies for 
fluorescence 2 (y-axis) were PE-labeled. 
The spleen of the same chimera revealed 
basically identical results (not shown). 
These data are representative for seven 
mice  reconstituted  with  cord  blood 
from five donors and tested between 
days  33 and 121  after grafting. 
that may lead to preferential expansion and repopulation with 
xenoreactive lymphocytes, although in our hands and in the 
hand of others (27)  there is no evidence for acute GVHD 
in the chimeras. V. A combination of mechanisms I-IV is 
also conceivable. 
Our studies did not provide evidence for human lymphopoi- 
esis  (possibility  I):  the  double-positive  T  cell phenotype 
(CD4+,CD8+),  which characterizes the major population 
of immature thymocytes, was seen rarely and in low numbers 
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in the chimeras at any time point (<4%  of the human T 
cells, Figs. 3 and 4). Mature, single-positive T cells prevailed 
from day 30 after transplantation, the earliest time point when 
human leukocytes could be detected in organs of the mice, 
through day 160, after which the human leukocytes usually 
were no longer detectable. When seen, CD4/CD8 double- 
positive T cells were present not only in primary lymphatic 
tissues (thymus, and possibly liver and spleen), but also in 
the lungs. All double-positive T  cells were CD3 +, CD1- 3 
2OO 
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Figure 5.  Cell cycle analysis of T 
cells  in  hu-PBbSCID  mice.  (A) 
Human T cells in the liver of a chi- 
mera 50 d after grafting with 2  x 
107 PBMC. The single-cell suspen- 
sion was  labeled with  anti-CD3- 
FITC  and  the DNA  was  stained 
with propidium iodide. The samples 
were studied by two-color FACS  | 
analysis.  The  DNA  content  is 
plotted versus the relative number 
of CD3 + cells. This is a represen- 
tative example of seven experiments 
on SCID mice that had been grafted 
with PBMC and cord blood 41 to 154 d before. (B) Freshly prepared, unstimulated PBMC of the same donor (antl-CD3 stained), and (C) leukemia 
cell line CEM are shown as controls. Since CEM does not express TCR on the surface, in (C) anti-CD45-FITC was used to label the cells. The percentage 
of cells in phases S, G2,  and M  of the cell cycle is indicated. 
CD45R.O + . This phenotype might be consistent with a lin- 
eage of immature T  cells that is committed to intrathymic 
death  (28,  29).  Alternatively,  the  CD45RO §  double- 
positive cells might represent mature, activated lymphocytes 
(30,  31)  that  can coexpress CD4 and CD8  (32-34).  Also, 
the double-positive cells in the thymus of the chimera could 
represent mature, activated cells that preferentially reenter this 
organ (35).  Since we did not detect (immature or mature) 
human T cells in SCID mice after grafting with stem cell-rich 
human thymus or bone marrow (Table  1),  we suggest that 
the rare CD4 § , CD8 § population in the chimeras  represents 
activated,  mature T  cells. 
Why human lymphopoiesis does not readily occur in SCID 
mice after transplantation of human stem cells is unclear.  It 
is possible that the human stem cells are rejected by NK cells 
(36) in the unmanipulated recipients. Alternatively,  the mu- 
fine hematopoietic stroma might not provide the appropriate 
microenvironment  (cytokines  and adhesion  molecules)  for 
Table  3.  Proliferative Responses of Chimera-derived Human  T  Cells 
Assay conditions  Exp.  1  Exp.  2 
Day  tested  T  APC  Ag  IL-2  A  no.  I(E)  A  no.  2(C)  A  no.  3(B)  A  no.  4  (E) 
0  +  -  -  -  3.4  _+  1.1  3.8  -+  0.4  5.9  +_  1.3  2.4  _+  0.1 
+  +  -  -  4.2  +_  1.1  4.1  +_  0.9  7.6  _+  0.3  4.9  _+  0.5 
+  +  txCD3  -  3.7  _+  0.9  3.1  _+  0.9  10.1  _+  0.8  3.5  -+  0.5 
+  +  cxCD3  +  43.6  _+  4.2  26.8  _+  5.7  37.2  _+  1.5  120.3  _+  2.3 
+  +  -  +  27.5  _+  1.2  20.1  _+  5.4  26.3  +  4.1  90.6  _+  1.2 
15  +  +  -  -  7.8  _+  0.6  10.6  _+  0.4  0.4  +_  0.1  0.7  +  0.1 
+  +  txCD3  -  18.5  _+  4.1  11.8  _+  0.2  1.2  _+  0.5  1.5  +_  0.1 
40  +  +  -  -  11.6  _+  3.2  3.7  _+  1.8  2.9  _+  0.1  53.9  +_  0.3 
+  +  txCD3  -  138.8  +  7.3  5.5  +-  1.1  3.5  -+  0.1  173.4  +_  13.6 
68  +  +  -  -  0.7  _+  0.03  0.9  _+  0.01  1.4  _+  0.1  2.6  -+  0.3 
+  +  etCD3  -  112.1  +  9.1  158.2  +  6.3  16.3  -+  2.3  198.2  +  2.7 
+  +  SCID  -  19.7  _+  3.9  1.3  _+  0.1  22.1  _+  0.9  27.2  _+  2.6 
Data obtained with four chimeras, representative of 11 tested, are shown. 95 d  after reconstitution with 2  x  107 PBMC (donors are identified by 
capital letters in parentheses), the mice were killed and single-cell suspensions from lungs, liver, and spleen were pooled. The chimera-derived cells 
were plated out at  106 total cells/well (0.3-2  x  105 human T  cells per well, as defined in retrospect by FACS|  Anti-CD3 antibody, rlL-2,  and 
APC (T cell-depleted, irradiated, human PBMC,  syngeneic to the donor) were added to the cultures as indicated (for further details see Materials 
and Methods). These primary in vitro cultures (day 0 results) were labeled with [3H]thymidine, harvested, and counted on day 5. Results (mean  _+  SD) 
are expressed as 3H incorporation (cpm  x  10 -3) of triplicate cultures. In parallel to the primary proliferation assay, human T  cell lines were initiat- 
ed from the individual chimeras (details for the initiation culture and the maintenance of the lines are described in Materials and Methods). The 
lines were retested after 15, 40,  and 68 d  of culture under the conditions indicated in a  standard proliferation assay.  Anergy in T  cells  was also 
seen when the chimeras were tested 41  and  176  d  after injection of human cells. 
512  Mature,  Anergic, Human T  Cells in Human Peripheral Blood SCID Mice human stem cell engraftment and differentiation. This no- 
tion is supported by the finding of others that after grafting 
SCID mice with fetal human liver and thymus, human he- 
matopoiesis does occur within but does not occur outside 
the human transplant (4, 7). 
The data in this report do not support the notion that 
the human leukocytes in the chimeras represent certain long- 
lived cell lineages which simply persist  in the mice (possi- 
bility II). We found evidence for an impressive expansion of 
the human leukocytes in the murine host. In the first 20 d 
after  intraperitoneal injection of 10  x  106 adult or cord 
blood cells, 0.01  x  106 human leukocytes (0.1%) were re- 
covered from the local site and no human cells were detected 
in other organs of the recipients (Table 1). This initial disap- 
pearance of the injected cells could be due to lack of survival 
of the vast majority of human leukocytes and/or their dis- 
semination in the mouse. Subsequently, the number of the 
human leukocytes gradually increased in all organs of the mice 
and usually peaked on day 50-70 after injection (Table 1). 
At this time point up to 50-100  x' 106 human cells (5-10 
times the inoculum) were recovered from lungs, liver, and 
spleen (Fig. 2 B) with an undefined number of human cells 
residing in those organs of the chimeras that cannot be readily 
analyzed by flow cytometry. The occurrence of high mitotic 
activity within the human leukocytes was confirmed by cell 
cycle studies (Fig.  5). 
The phenotype conversion of the human T cells also argues 
against  simple persistence  of mature cells  in  SCID  mice 
(possibility II): T lymphocytes recovered from cord blood- 
engrafted chimeras all expressed the phenotype CD45RA-, 
CD45KO + (memory cells, Fig.  4) but all the T  lympho- 
cytes in the inoculum were CD45RA + ,CD45RO-  (virgin 
cells, our own data, and reference 37). Similarly, after injec- 
tion of adult PBL, consisting of roughly equal numbers of 
memory and virgin T cells (our own data and reference 37, 
38),  only CD45RA-,CD45RO + T  lymphocytes were de- 
tected in the mice (Fig. 3). Furthermore, MHC class II (HLA- 
DK)-positive T cells, that are virtually absent in cord blood 
and represent a minor population in adult blood, constituted 
the vast majority of T lymphocytes in the chimeras (Fig. 3 
K,  Fig.  4 J, K,  and L). 
Our data demonstrate that repopulation of SCID mice is 
dominated by two lymphocyte lineages.  A  heterogeneous 
population of human leukocytes was transferred into the mice, 
but only two human cell populations were recovered: oe/3 
T cells and B lymphocytes. In all experiments, the non-T cell 
(CD3-)  population was identified as  B cells (CD19 + or 
CD20 +), and we did not detect human cells of a nonleuko- 
cyte origin in the chimeras (lack of CD45 - ,H-2K  d- cells in 
Fig.  3 A). 
One possible interpretation of our data is that SCID mice 
are repopulated with a subset  of self-replenishing,  mature, 
human lymphocytes, which proliferate in the secondary host 
independently of stimulation by antigen (possibility III). For 
example, it is conceivable that the total number of lympho- 
cytes in the body is regulated (25). Thus, when lymphocyte 
counts drop beyond a critical level, clonal expansion within 
the mature population would result until the normal cell 
number is reestablished.  According to this model, a regula- 
tory mechanism would induce human leukocytes to proliferate 
in SCID mice until they reach the regular density (300 mil- 
lion lymphocytes/mouse).  This homeostatic model might not 
be compatible with our following data:  (a) After reaching 
its peak value on days 50-70, the number of human lympho- 
cytes steadily declines in the chimeras (Table 1). (b) As  judged 
by cell cycle studies the human leukocytes still proliferate in 
the chimeras at time points, when the absolute number of 
human cells drops in the mice (data not shown). (c) The pheno- 
type of the human T  cells is rather uniform and does not 
change from early to late stages of chimerism. To resolve these 
data from the homeostatic model one would have to postu- 
late that: the number of human leukocytes never reaches the 
critical level in SCID mice and therefore the proliferation- 
inducing stimulus persists; the potential for self-replenishing 
is exhaustible;  the self-replenishing  cell types have a short 
life span;  and only CD45RA-,CD45KO § T  cells (along 
with some undefined B cells) are responding to this type of 
regulation. This T memory cell-like phenotype could either 
represent a distinct T cell subpopulation with self-replenishing 
capacity,  or several T  cell lineages might proliferate  in re- 
sponse to the assumed homeostatic regulation and the memory 
cell-like phenotype would be expressed by cycling cells. 
GVH reactivity (possibility IV) could also account for our 
data regarding the nature of the engrafted human T  cells. 
There is clearly the potential for GVH reactions after transfer 
of mature human cells into SCID mice. In our hands SCID- 
splenic stimulator cells triggered in vitro proliferative responses 
by human PBL that were comparable in magnitude with clas- 
sical, human MLR (M. Tary-Lehmann, unpublished data). 
Therefore, (at least under the in vitro conditions) SCID APC 
provide across the species barrier for all signals for activation 
of xenoreactive human T cells. Moreover, the vigorous human 
anti-SCID MLR suggests that the frequency ofxenoreactive 
human T lymphocytes is in the range of alloreactive T cell 
populations (1-10%  of the T  cell pool) (39). 
In addition the phenotype of the human T  cells in the 
chimeras is consistent with lymphocytes that had been re- 
cently activated by antigen recognition (CD45KO + , HLA- 
DR +, Figs. 3 and 4). As with stimulated T cells, the lym- 
phocytes in the chimeras do not express  the lymph node 
homing receptor Leu8 (Fig. 3) (40-43).  Accordingly, only 
few cells were found in the lymph nodes of the chimeras, 
but the majority of T cells were recovered in the lungs, liver, 
and spleen of the chimeras (Fig. 2 B). In fact, this tissue dis- 
tribution reflects homing patterns of activated T cells. Such 
cells migrate preferentially to lungs, liver, and other periph- 
eral tissues (19), but, lacking the Leu8 homing receptor,  do 
not migrate to lymph nodes (42, 43).  Under conditions of 
chronic T cell stimulation, e.g., during GVHD, T cells do 
not express increased levels of IL-2 receptor (44-46). Consis- 
tent with this observation, the human T cells in the chimera 
were negative for this activation marker (data not shown). 
Given that the assumption was correct that xenoreactivity 
is the basis for selection and expansion of human T lympho- 
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of GVHD? Based on current concepts about alloreactive T 
cell recognition, the following scenarios can be envisaged for 
the xenoreactive constellation in SCID human chimeras.  First, 
xenoreactive human T  cells recognize native murine MHC 
(H-2) molecules on SCID APC, probably involving presen- 
tation of peptides of either murine  or human  origin  (47). 
To be stimulatory in this context, SCID APC had to express 
sufficient levels of H-2 antigens and accessory molecules (in 
the absence of endogenous lymphokines, expression of these 
molecules might be low in SCID mice).  Furthermore,  an- 
tigen presentation had to be functional across the species bar- 
rier,  i.e., the routine APC had to be able to also provide the 
"second signal"  which is known  to be required for T  cell 
activation beyond T  cell receptor occupancy (48).  It is un- 
known which of these conditions are met when SCID mice 
are engrafted with human PBL. For example, in the absence 
of the costimulatory signal, abortive T cell responses could 
result (48, 49).  This type of T  cell stimulation  could lead 
to anergization of the xenoreactive human T cell population 
in  the chimeras  (see below). 
The second possibility for the xenoreactive constellation 
in SCID human  chimeras is that  human  T  cells  recognize 
murine antigens (H-2 or other gene products) in a processed 
form presented by the autologous APC, i.e.,  the xeno-re- 
sponse would be restricted to the donor's  HLA molecules 
(50). It is important that the targets of this type of xenoreac- 
tivity would be human but not murine cells,  and  that  the 
outcome would be self-destruction by donor cells rather than 
an attack against host tissues. This model could account for 
both the lack of GVHD in the chimeras, as well as the self- 
limiting nature of the repopulation of SCID mice with human 
lymphocytes reported here. The requirement of human APC 
for the anti-SCID proliferative response by the chimera-derived 
T  cell lines  (data not shown) might also support this latter 
model. 
The human T cells, freshly isolated from the chimeras, did 
not respond to stimulation by anti-CD3  antibody or PHA 
as measured by proliferation (Table 3) and I1:2 secretion (data 
not  shown).  However, the T  cells proliferated in the pres- 
ence of I1:2. Thus we succeeded to establish long-term human 
T  cell lines from hu-PBL-SCID mice. The lines retained the 
state of unresponsiveness for  15 to 40 d,  after which  they 
became responsive to triggering via the TCR (Table 3). This 
type of reversible anergy has been observed after Th cell stim- 
ulation,  in the absence of the second signal  (48,  49).  It is 
significant that antigen presentation by T  (51,  52) and also 
by B cells (53, 54) has been demonstrated to induce anergy. 
Since T  and B cells are the only human leukocytes we de- 
tected in the chimeras,  and, since both cell types express MHC 
class II molecules in the mice (Figs. 3 and 4), HLA-restricted 
recognition of murine antigens in hu-PBbSCID mice is prone 
to induce anergy in the xenoreactive human T  cell popula- 
tion.  But,  as  stated  above,  H-2-restricted  xenoreactive re- 
sponses, which involve direct recognition of murine APC, 
might also lead to anergy if the second signal is not delivered 
across the species barrier.  In vivo, induction  of anergy can 
be preceded by an initial phase of proliferation which is fol- 
lowed by contraction  of the clonal size (55).  Thus,  the ki- 
netics of repopulation of SCID mice with human leukocytes 
(Table 1) might  be consistent with xenoreactive human  T 
cell responses. 
After the T cell lines overcome the anergic state, most lines 
(9 of 11) revealed proliferative responses to SCID splenic stimu- 
lator cells.  The lines that did not respond consisted mainly 
of CD8 §  human  T  cells.  These  data  clearly demonstrate 
that proliferative, xenoreactive human T  ceils were present 
in the majority of the chimeras. However, it remains unclear 
whether xenoreactive T cells constituted the dominant popu- 
lation in the mice.  Also,  the specificity of the CD8 + cells 
has not been defined yet. The complete lack of proliferative 
response to anti-CD3 triggered activation in freshly isolated 
cells from the chimeras (Table 3) demonstrates that the vast 
majority of human  T  cells were refractory to stimulation. 
This might suggest that most of the T cells in the chimeras 
are anergized as a consequence of their xenoreactive antigen 
specificity.  However, GVH reactivity is associated with a se- 
vere,  generalized immunodeficiency which has been attrib- 
uted to non-antigen-specific suppression mediated by CD8* 
and CD4 § T cells (56, 57). In the latter case, a minor popu- 
lation of xenoreactive T cells could reversibly abolish the re- 
sponse of a major, nonxenoreactive T cell population. There- 
fore,  in conclusion,  though  we have clearcut  evidence for 
xenoreactivity in hu-PBL-SCID chimeras,  we cannot formally 
define whether  the human  immune  system in  the mice is 
characterized by (a) a dominant, self-replenishing  T cell popu- 
lation that  proliferates in the absence of antigenic  stimula- 
tion and has a minor xenoreactive component; or (b) whether 
xenoreactivity is the major, if not only stimulus for repopu- 
lation of SCID mice with human T  cells. Currently we are 
performing experiments to distinguish between these possi- 
bilities. 
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